Related Experiment Videos
Interaction of silver nanoparticles with HIV-1
Jose Luis Elechiguerra1, Justin L Burt, Jose R Morones
1Department of Chemical Engineering, The University of Texas, Austin, Texas 78712, USA. josee@che.utexas.edu
Journal of Nanobiotechnology
|July 1, 2005
Summary
Silver nanoparticles (1-10 nm) bind to HIV-1's gp120 glycoprotein knobs, inhibiting viral attachment to host cells. This size-dependent interaction offers a novel antiviral strategy.
Area of Science:
- Nanotechnology
- Virology
- Biochemistry
Background:
- Research on nanoparticle-biomolecule interactions is growing.
- Metal nanoparticle interaction with viruses remains largely unexplored.
Purpose of the Study:
- Investigate the interaction between silver nanoparticles (AgNPs) and the Human Immunodeficiency Virus type 1 (HIV-1).
- Determine the effect of AgNPs on HIV-1 binding to host cells.
Main Methods:
- Characterization of AgNP-HIV-1 interactions, focusing on nanoparticle size.
- In vitro assays to assess the inhibition of HIV-1 binding to host cells.
Main Results:
- AgNPs in the 1-10 nm size range selectively attached to HIV-1.
- Evidence suggests preferential binding to gp120 glycoprotein knobs on the virus surface.
- This interaction effectively inhibited HIV-1's ability to infect host cells in vitro.
Conclusions:
- Silver nanoparticles exhibit a size-dependent interaction with HIV-1.
- AgNPs interfere with HIV-1 attachment to host cells by binding to gp120.
- This finding presents a potential new avenue for antiviral therapies.